Repair of O6-methylguanine is not affected by thymine base pairing and the presence of MMR proteins

Jochen Lips, Bernd Kaina
{"title":"Repair of O6-methylguanine is not affected by thymine base pairing and the presence of MMR proteins","authors":"Jochen Lips,&nbsp;Bernd Kaina","doi":"10.1016/S0921-8777(01)00105-7","DOIUrl":null,"url":null,"abstract":"<div><p><span>Methylation at the </span><em>O</em><sup>6</sup><span>-position of guanine (</span><em>O</em><sup>6</sup>-MeG) by alkylating agents is efficiently removed by <em>O</em><sup>6</sup>-methylguanine–DNA methyltransferase (MGMT), preventing from cytotoxic, mutagenic, clastogenic and carcinogenic effects of <em>O</em><sup>6</sup>-MeG-inducing agents. If <em>O</em><sup>6</sup><span><span>-MeG is not removed from DNA prior to replication, thymine will be incorporated instead of </span>cytosine opposite the </span><em>O</em><sup>6</sup><span><span>-MeG lesion. This mismatch is recognized and processed by mismatch repair (MMR) proteins which are known to be involved in triggering the cytotoxic and genotoxic response of cells upon methylation. In this work we addressed three open questions. (1) Is </span>MGMT able to repair </span><em>O</em><sup>6</sup>-MeG mispaired with thymine (<em>O</em><sup>6</sup>-MeG/T)? (2) Do MMR proteins interfere with the repair of <em>O</em><sup>6</sup>-MeG/T by MGMT? (3) Does MGMT show a protective effect if it is expressed after replication of DNA containing <em>O</em><sup>6</sup><span><span>-MeG? Using an in vitro assay we show that </span>oligonucleotides containing </span><em>O</em><sup>6</sup>-MeG/T mismatches are as efficient as oligonucleotides containing <em>O</em><sup>6</sup>-MeG/C in competing for MGMT repair activity, indicating that <em>O</em><sup>6</sup>-MeG mispaired with thymine is still subject to repair by MGMT. The addition of MMR proteins from nuclear extracts, or of recombinant MutSα, to the in vitro repair assay did not affect the repair of <em>O</em><sup>6</sup>-MeG/T lesions by MGMT. This indicates that the presence of MutSα still allows access of MGMT to <em>O</em><sup>6</sup>-MeG/T lesions. To elucidate the protective effect of MGMT in the first and second replication cycle after <em>N</em>-methyl-<em>N</em>′-nitro-<em>N</em>-nitrosoguanidine (MNNG) treatment, MGMT transfected CHO cells were synchronized and MGMT was inactivated by pulse-treatment with <em>O</em><sup>6</sup>-benzylguanine (<em>O</em><sup>6</sup>-BG). Thereafter, the recovered cells were treated with MNNG and subjected to clonogenic survival assays. Cells which expressed MGMT in the first and second cell cycle were more resistant than cells which expressed MGMT only in the second (post-treatment) cell cycle. Cells which did not express MGMT in both cell cycles were most sensitive. This indicates that repair of <em>O</em><sup>6</sup><span>-MeG can occur both in the first and second cell cycle after alkylation protecting cells from the killing effect of the lesion.</span></p></div>","PeriodicalId":100935,"journal":{"name":"Mutation Research/DNA Repair","volume":"487 1","pages":"Pages 59-66"},"PeriodicalIF":0.0000,"publicationDate":"2001-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0921-8777(01)00105-7","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mutation Research/DNA Repair","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0921877701001057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19

Abstract

Methylation at the O6-position of guanine (O6-MeG) by alkylating agents is efficiently removed by O6-methylguanine–DNA methyltransferase (MGMT), preventing from cytotoxic, mutagenic, clastogenic and carcinogenic effects of O6-MeG-inducing agents. If O6-MeG is not removed from DNA prior to replication, thymine will be incorporated instead of cytosine opposite the O6-MeG lesion. This mismatch is recognized and processed by mismatch repair (MMR) proteins which are known to be involved in triggering the cytotoxic and genotoxic response of cells upon methylation. In this work we addressed three open questions. (1) Is MGMT able to repair O6-MeG mispaired with thymine (O6-MeG/T)? (2) Do MMR proteins interfere with the repair of O6-MeG/T by MGMT? (3) Does MGMT show a protective effect if it is expressed after replication of DNA containing O6-MeG? Using an in vitro assay we show that oligonucleotides containing O6-MeG/T mismatches are as efficient as oligonucleotides containing O6-MeG/C in competing for MGMT repair activity, indicating that O6-MeG mispaired with thymine is still subject to repair by MGMT. The addition of MMR proteins from nuclear extracts, or of recombinant MutSα, to the in vitro repair assay did not affect the repair of O6-MeG/T lesions by MGMT. This indicates that the presence of MutSα still allows access of MGMT to O6-MeG/T lesions. To elucidate the protective effect of MGMT in the first and second replication cycle after N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) treatment, MGMT transfected CHO cells were synchronized and MGMT was inactivated by pulse-treatment with O6-benzylguanine (O6-BG). Thereafter, the recovered cells were treated with MNNG and subjected to clonogenic survival assays. Cells which expressed MGMT in the first and second cell cycle were more resistant than cells which expressed MGMT only in the second (post-treatment) cell cycle. Cells which did not express MGMT in both cell cycles were most sensitive. This indicates that repair of O6-MeG can occur both in the first and second cell cycle after alkylation protecting cells from the killing effect of the lesion.

o6 -甲基鸟嘌呤的修复不受胸腺嘧啶碱基配对和MMR蛋白存在的影响
烷基化剂在鸟嘌呤(O6-MeG) o6位的甲基化被o6 -甲基鸟嘌呤- dna甲基转移酶(MGMT)有效去除,从而防止O6-MeG诱导剂的细胞毒性、致突变、致裂和致癌作用。如果在复制之前没有从DNA中去除O6-MeG,则胸腺嘧啶将取代O6-MeG病变对面的胞嘧啶。这种错配是由错配修复(MMR)蛋白识别和处理的,已知该蛋白参与触发甲基化后细胞的细胞毒性和基因毒性反应。在这项工作中,我们解决了三个悬而未决的问题。(1) MGMT是否能够修复O6-MeG与胸腺嘧啶错配(O6-MeG/T)?(2) MMR蛋白是否干扰MGMT对O6-MeG/T的修复?(3) MGMT在含有O6-MeG的DNA复制后表达,是否有保护作用?通过体外实验,我们发现含有O6-MeG/T错配的寡核苷酸与含有O6-MeG/C的寡核苷酸一样有效地竞争MGMT修复活性,这表明O6-MeG与胸腺嘧啶错配仍然受到MGMT修复的影响。在体外修复实验中加入核提取物中的MMR蛋白或重组MutSα蛋白并不影响MGMT对O6-MeG/T病变的修复。这表明MutSα的存在仍然允许MGMT进入O6-MeG/T病变。为了阐明MGMT在n -甲基-n ' -硝基-n -亚硝基鸟嘌呤(MNNG)处理后的第一和第二复制周期中的保护作用,将转染MGMT的CHO细胞同步化,并通过o6 -苄基鸟嘌呤(O6-BG)脉冲处理使MGMT灭活。然后,将恢复的细胞用MNNG处理并进行克隆存活试验。在第一个和第二个细胞周期中表达MGMT的细胞比仅在第二个(处理后)细胞周期中表达MGMT的细胞更耐药。在两个细胞周期中均未表达MGMT的细胞最为敏感。这表明O6-MeG的修复可以发生在烷基化后的第一个和第二个细胞周期,保护细胞免受病变的杀伤作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信